Blood biomarkers predicting adverse clinical outcomes in congenital heart disease patients, with consideration for pulmonary valve replacement

Publié en ligne: 29 mars 2023

Pages: 11 - 16

Reçu: 20 oct. 2022

Accepté: 14 févr. 2023

DOI: https://doi.org/10.2478/amma-2023-0009

Mots clés

congenital heart disease, tetralogy of Fallot, pentalogy of Fallot, blood biomarkers, pulmonary valve replacement

© 2023 Milla Marika Kainlauri et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.